Breast Milk News and Research

RSS

Studies stress the importance of vitamin D intake during first year of life

Everyone seems to agree that vitamin D is important throughout life. This is certainly as true in the first year of life as it is later on.

9 Jun 2014

State highlights: Mental health funding in Kansas; EHR problems claim CEO's job; 'litany of woes' at IHS

A selection of health policy stories from Arkansas, Florida, Georgia, Kansas, Michigan, Montana, Ohio, and Wyoming.

29 May 2014

Orexo US partners with inVentiv Health to market Zubsolv sublingual tablets in the US

Orexo AB announces a new partnership between Orexo US, Inc. and inVentiv Health for the commercialization of Zubsolv in the US.

20 May 2014

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.

8 May 2014

Important steps that women should take before, during and after pregnancy

Being a mother involves major responsibilities and love. That's why it's important to take steps before, during and after pregnancy.

2 May 2014

Study: Genetics as well as environment in womb play important roles in development of baby

A recent study led by A*STAR's Singapore Institute for Clinical Sciences (SICS) found that genetics as well as the environment in the womb play important roles in the development of the baby.

29 Apr 2014

Study: Maternal diet could have impact on food allergy in later life of children

About 20 million Europeans are subject to food allergies. Now scientists are looking at these allergies in new ways. It involves the food industry in its work and pays special attention to the link between early diets and allergy in later life. Clare Mills, professor of allergy in the university's Institute of Inflammation and Repair, at the University of Manchester, UK, is the coordinator of iFAAM.

21 Apr 2014

Probiotics usage proves ineffective for infant colic symptoms

Colic affects about one in five infants in the United States annually and accounts for numerous pediatric visits during the first several months after birth.

18 Apr 2014

Women on antidepressant medication are more successful at breastfeeding

University of Adelaide researchers have found that women on antidepressant medication are more successful at breastfeeding their babies if they keep taking the medication, compared with women who quit antidepressants because of concerns about their babies' health.

11 Apr 2014

Study shows link between breast-feeding and risk of child developing obesity

Many studies have focused on the influence of breast-feeding on child health. From analysis of data from the ELANCE cohort, Marie Fran-oise Rolland-Cachera, former researcher at Inserm and her co-workers in the Nutritional Epidemiology Research Team (EREN) have shown that breast-feeding has a protective effect on the risk of obesity at 20 years of age.

2 Apr 2014

Medolac Laboratories opens new center of operations in Lake Oswego, Oregon

Many local and state dignitaries, investors, employees, donors and media, participated in the ribbon cutting ceremony on Thursday, March 27, 2014 to help christen Medolac Laboratories' flagship center of operations in Lake Oswego, Oregon.

31 Mar 2014

Toxicologists reveal new methods for estimating infants' exposure to POPs

Toxicologists are revealing new methods and models for estimating infants' exposure to persistent organic pollutants (POPs) today at the Society of Toxicology (SOT) 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.

26 Mar 2014

FDA approves Xolair for treatment of chronic idiopathic urticaria

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, a form of chronic hives.

24 Mar 2014

Orexo signs multi-year agreement with OptumRx and UnitedHealth Group

Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.

12 Mar 2014

Professor receives $17M NIH grant to support IMPAACT Network

Grace Aldrovandi, MD, CM, principal investigator at The Saban Research Institute of Children's Hospital Los Angeles, has been awarded $17 million by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

20 Feb 2014

Tips to maintain heart-healthy lifestyle for kids and adolescents

It's never too early for you to start taking care of your heart.

6 Feb 2014

Support from lactation consultant improves chances of breastfeeding

In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at least for a few months-long enough for mother and child to gain health benefits. The results of the trials were published online today in American Journal of Public Health.

28 Dec 2013

Physicians study mothers' breast milk to determine correct amounts of nutrients for premature infants

Physicians in the Neonatal Intensive Care Unit in the Maxine Dunitz Children's Health Center launched a pilot study in which mothers' breast milk is analyzed to determine whether premature infants are receiving the correct amounts of nutrients they need to thrive.

24 Dec 2013

Periodic meetings with lactation consultant improves chances of breastfeeding

In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at least for a few months—long enough for mother and child to gain health benefits.

20 Dec 2013

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.

16 Dec 2013